Membership
Members' Area
Get Involved
Events
Education
Science policy
Publications
Grants
Awards
About Us

Scientific Meetings and Training Events

The Biochemical Society provides an extensive range of events, including scientific conferences, outreach activities, medal lectures and policy and education events.  

 

Contact our events team here.

 

Find out about our policy and public engagement events:

     

 

Future Events > Key aspects of modern drug discovery

Key aspects of modern drug discovery

29—30 October 2018

Charles Darwin House, London



A Biochemical Society and Royal Society of Chemistry Training Event

 



Earlybird registration deadline: 28 September 2018 - This event has now SOLD OUT - if you would like to be added to the waiting list please email conferences@biochemistry.org

 

This training event aims to provide a comprehensive overview of the pre-clinical drug discovery process. Designed and delivered by experts from industry and academia, the event is suitable for recent graduates, PhD students and early career scientists interested in working in the pre-clinical drug discovery industry.

 

The course will focus on small molecule target identification and validation, hit-to-lead and lead optimisation, as well as on pre-clinical drug development and toxicology. ‘Key aspects of modern drug discovery’ will comprise lectures, case studies, group discussions and a drinks reception to encourage networking and collaboration among delegates and speakers.

 

Speakers include:

 

-               Rick Davies, AstraZeneca

-               Jacqui Piner, GSK

-               John Unitt, Sygnature Discovery

-               Heather Wallace, University of Aberdeen

-               Rupert Satchell, Sygnature Discovery

-               Andy Davis, AstraZeneca

-               John Ladbury, University of Leeds

 

The event is developed in collaboration with the Royal Society of Chemistry, and it is supported by the Royal Society of Biology and the British Pharmacological Society.

 

Event supporters: